𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Amsacrine treatment of patients with supraventricular arrhythmias and acute leukemia

✍ Scribed by Zalmen Arlin; Rakesh Mehta; Eric Feldman; Phyllis Sullivan; Anthony Pucillo

Publisher
Springer
Year
1987
Tongue
English
Weight
157 KB
Volume
19
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

✦ Synopsis

Three patients with a history of supraventricular arrhythmia presented with relapse of acute leukemia. Two of the three patients were in sinus rhythm, receiving digoxin and/or verapamil daily. The third patient was in atrial fibrillation, but her heart rate was controlled with daily digoxin. All three patients received amsacrine without the occurrence of cardiac events. Although amsacrine may cause ventricular arrhythmias in the setting of hypokalemia, correction of the electrolyte abnormality permits its use in patients with a history of supraventricular arrhythmias.

πŸ“œ SIMILAR VOLUMES

Amsacrine and etoposide induced paralyti
Amsacrine and etoposide induced paralytic ileus in a patient with acute myelomonocytic leukemia
✍ Omer Kucuk; James V. Apostol πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 227 KB πŸ‘ 1 views

## Abstract A 73‐year‐old man with acute myelomonocytic leukemia developed a severe paralytic ileus after amsacrine and etoposide treatment. The ileus did not respond to treatment with gastric suction and intravenous fluids. Autonomic neuropathy induced by anti‐neoplastic drugs may lead to this lif

Amsacrine is safe and effective therapy
Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia
✍ Zalmen A. Arlin; Eric J. Feldman; Abraham Mittelman; Tauseef Ahmed; Carmelo Pucc πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 306 KB πŸ‘ 2 views

The role of amsacrine in inducing remission in patients with cardiac disease and acute leukemia was evaluated. There were 17 patients with acute myelogenous leukemia (AML), six with acute lymphocytic leukemia (ALL), and one with biphenotypic leukemia. In this series of 24 patients whose disease had